Julia A. Haller - Aug 11, 2022 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Director
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
Stock symbol
OTLK
Transactions as of
Aug 11, 2022
Transactions value $
$0
Form type
4
Date filed
8/15/2022, 05:16 PM
Previous filing
Jul 5, 2022
Next filing
Oct 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OTLK Stock Option (Right to Buy) Award $0 +25K $0.00 25K Aug 11, 2022 Common Stock 25K $1.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in three equal installments on each of August 11, 2023, August 11, 2024 and August 11, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan.